Fujibayashi Y - Search Results

1

Copper-64-pyruvaldehyde-bis(N(4)-methylthiosemicarbazone) for the prevention of tumor growth at wound sites following laparoscopic surgery: monitoring therapy response with microPET and magnetic resonance imaging.

Lewis JS, Connett JM, Garbow JR, Buettner TL, Fujibayashi Y, Fleshman JW, Welch MJ. Lewis JS, et al. Among authors: fujibayashi y. Cancer Res. 2002 Jan 15;62(2):445-9. Cancer Res. 2002. PMID: 11809694

2

Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone).

Lewis JS, Herrero P, Sharp TL, Engelbach JA, Fujibayashi Y, Laforest R, Kovacs A, Gropler RJ, Welch MJ. Lewis JS, et al. Among authors: fujibayashi y. J Nucl Med. 2002 Nov;43(11):1557-69. J Nucl Med. 2002. PMID: 12411560 Free article.

3

Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model.

Lewis JS, McCarthy DW, McCarthy TJ, Fujibayashi Y, Welch MJ. Lewis JS, et al. Among authors: fujibayashi y. J Nucl Med. 1999 Jan;40(1):177-83. J Nucl Med. 1999. PMID: 9935074 Free article.

4

Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy.

Lewis J, Laforest R, Buettner T, Song S, Fujibayashi Y, Connett J, Welch M. Lewis J, et al. Among authors: fujibayashi y. Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1206-11. doi: 10.1073/pnas.98.3.1206. Proc Natl Acad Sci U S A. 2001. PMID: 11158618 Free PMC article.

5

Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation.

Lewis JS, Sharp TL, Laforest R, Fujibayashi Y, Welch MJ. Lewis JS, et al. Among authors: fujibayashi y. J Nucl Med. 2001 Apr;42(4):655-61. J Nucl Med. 2001. PMID: 11337556 Free article.

6

Cytosolic/microsomal redox pathway: a reductive retention mechanism of a PET-oncology tracer, cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (cu-PTSM).

Shibuya K, Fujibayashi Y, Yoshimi E, Sasai K, Hiraoka M, Welch MJ. Shibuya K, et al. Among authors: fujibayashi y. Ann Nucl Med. 1999 Oct;13(5):287-92. doi: 10.1007/BF03164865. Ann Nucl Med. 1999. PMID: 10582796

7

Evaluation of 62Cu labeled diacetyl-bis(N4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer.

Takahashi N, Fujibayashi Y, Yonekura Y, Welch MJ, Waki A, Tsuchida T, Sadato N, Sugimoto K, Itoh H. Takahashi N, et al. Among authors: fujibayashi y. Ann Nucl Med. 2000 Oct;14(5):323-8. doi: 10.1007/BF02988690. Ann Nucl Med. 2000. PMID: 11108159

8

Intra-tumoral distribution of (64)Cu-ATSM: a comparison study with FDG.

Obata A, Yoshimoto M, Kasamatsu S, Naiki H, Takamatsu S, Kashikura K, Furukawa T, Lewis JS, Welch MJ, Saji H, Yonekura Y, Fujibayashi Y. Obata A, et al. Among authors: fujibayashi y. Nucl Med Biol. 2003 Jul;30(5):529-34. doi: 10.1016/s0969-8051(03)00047-7. Nucl Med Biol. 2003. PMID: 12831991

9

Internal radiotherapy with copper-64-diacetyl-bis (N4-methylthiosemicarbazone) reduces CD133+ highly tumorigenic cells and metastatic ability of mouse colon carcinoma.

Yoshii Y, Furukawa T, Kiyono Y, Watanabe R, Mori T, Yoshii H, Asai T, Okazawa H, Welch MJ, Fujibayashi Y. Yoshii Y, et al. Among authors: fujibayashi y. Nucl Med Biol. 2011 Feb;38(2):151-7. doi: 10.1016/j.nucmedbio.2010.08.009. Epub 2010 Oct 27. Nucl Med Biol. 2011. PMID: 21315269

10

Retention mechanism of hypoxia selective nuclear imaging/radiotherapeutic agent cu-diacetyl-bis(N4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells.

Obata A, Yoshimi E, Waki A, Lewis JS, Oyama N, Welch MJ, Saji H, Yonekura Y, Fujibayashi Y. Obata A, et al. Among authors: fujibayashi y. Ann Nucl Med. 2001 Dec;15(6):499-504. doi: 10.1007/BF02988502. Ann Nucl Med. 2001. PMID: 11831397

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters